These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25356177)

  • 1. Docosahexaenoic acid has an anti-diabetic effect in streptozotocin-induced diabetic mice.
    Li P; Zhang L; Tian X; Xing J
    Int J Clin Exp Med; 2014; 7(9):3021-9. PubMed ID: 25356177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonic delivery of docosahexaenoic acid improves impaired glucose tolerance via GLP-1 secretion and suppresses pancreatic islet hyperplasia in diabetic KK-A(y) mice.
    Shida T; Kamei N; Takeda-Morishita M; Isowa K; Takayama K
    Int J Pharm; 2013 Jun; 450(1-2):63-9. PubMed ID: 23618969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of colon targeted DHA and EPA as novel diabetes medications that promote intrinsic GLP-1 secretion.
    Morishita M; Tanaka T; Shida T; Takayama K
    J Control Release; 2008 Dec; 132(2):99-104. PubMed ID: 18804128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice.
    McKillop AM; Moran BM; Abdel-Wahab YH; Gormley NM; Flatt PR
    Diabetologia; 2016 Dec; 59(12):2674-2685. PubMed ID: 27677765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rehmannia glutinosa (Gaertn.) DC. polysaccharide ameliorates hyperglycemia, hyperlipemia and vascular inflammation in streptozotocin-induced diabetic mice.
    Zhou J; Xu G; Yan J; Li K; Bai Z; Cheng W; Huang K
    J Ethnopharmacol; 2015 Apr; 164():229-38. PubMed ID: 25698243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer's Disease-Like Complications of Diabetes.
    Pardeshi R; Bolshette N; Gadhave K; Arfeen M; Ahmed S; Jamwal R; Hammock BD; Lahkar M; Goswami SK
    Front Pharmacol; 2019; 10():288. PubMed ID: 31068802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of DHA-rich fish oil on PPARγ target genes related to lipid metabolism in type 2 diabetes: A randomized, double-blind, placebo-controlled clinical trial.
    Mansoori A; Sotoudeh G; Djalali M; Eshraghian MR; Keramatipour M; Nasli-Esfahani E; Shidfar F; Alvandi E; Toupchian O; Koohdani F
    J Clin Lipidol; 2015; 9(6):770-777. PubMed ID: 26687697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dietary docosahexaenoic acid on the endothelium-dependent vasorelaxation in diabetic rats.
    Goirand F; Ovide-Bordeaux S; Renaud JF; Grynberg A; Lacour B
    Clin Exp Pharmacol Physiol; 2005 Mar; 32(3):184-90. PubMed ID: 15743401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-hyperglycemic activity of myricetin, through inhibition of DPP-4 and enhanced GLP-1 levels, is attenuated by co-ingestion with lectin-rich protein.
    Lalitha N; Sadashivaiah B; Ramaprasad TR; Singh SA
    PLoS One; 2020; 15(4):e0231543. PubMed ID: 32282828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of docosahexaenoic acid-enriched phospholipids in experimental diabetic neuropathy.
    Coste TC; Gerbi A; Vague P; Pieroni G; Raccah D
    Diabetes; 2003 Oct; 52(10):2578-85. PubMed ID: 14514643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Team Players or Opponents: Coadministration of Selective Glucagon and GLP-1 Receptor Agonists in Obese Diabetic Monkeys.
    Elvert R; Bossart M; Herling AW; Weiss T; Zhang B; Kannt A; Wagner M; Haack T; Evers A; Dudda A; Keil S; Lorenz M; Lorenz K; Riz M; Hennerici W; Larsen PJ
    Endocrinology; 2018 Aug; 159(8):3105-3119. PubMed ID: 29992313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-obesity effect of fish oil and fish oil-fenofibrate combination in female KK mice.
    Arai T; Kim HJ; Chiba H; Matsumoto A
    J Atheroscler Thromb; 2009 Oct; 16(5):674-83. PubMed ID: 19907107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CB-1R and GLP-1R gene expressions and oxidative stress in the liver of diabetic rats treated with sitagliptin.
    Coskun ZM; Koyuturk M; Karabulut S; Bolkent S
    Pharmacol Rep; 2017 Aug; 69(4):822-829. PubMed ID: 28599244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulinotropic effects of GPR120 agonists are altered in obese diabetic and obese non-diabetic states.
    Zhang D; So WY; Wang Y; Wu SY; Cheng Q; Leung PS
    Clin Sci (Lond); 2017 Feb; 131(3):247-260. PubMed ID: 27980130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute antinociceptive effect of fish oil or its major compounds, eicosapentaenoic and docosahexaenoic acids on diabetic neuropathic pain depends on opioid system activation.
    Redivo DDB; Jesus CHA; Sotomaior BB; Gasparin AT; Cunha JM
    Behav Brain Res; 2019 Oct; 372():111992. PubMed ID: 31152745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docosahexanoic acid (DHA) improved glucose and lipid metabolism in KK-Ay mice with genetic non-insulin-dependent diabetes mellitus (NIDDM).
    Shimura T; Miura T; Usami M; Ishihara E; Tanigawa K; Ishida H; Seino Y
    Biol Pharm Bull; 1997 May; 20(5):507-10. PubMed ID: 9178930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
    Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
    Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dietary docosahexaenoic acid connecting phospholipids on the lipid peroxidation of the brain in mice.
    Hiratsuka S; Ishihara K; Kitagawa T; Wada S; Yokogoshi H
    J Nutr Sci Vitaminol (Tokyo); 2008 Dec; 54(6):501-6. PubMed ID: 19155590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of glucagon-like peptide-2 (GLP-2) is involved in pancreatic islet cell adaptations to stress and beta-cell survival.
    Khan D; Vasu S; Moffett RC; Irwin N; Flatt PR
    Peptides; 2017 Sep; 95():68-75. PubMed ID: 28746825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.
    Maida A; Lovshin JA; Baggio LL; Drucker DJ
    Endocrinology; 2008 Nov; 149(11):5670-8. PubMed ID: 18669601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.